American Regent reported on Thursday the availability of Hydroxyprogesterone Caproate Injection, USP in a 250 mg/ml, 1ml preservative free Single Dose Vial to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.

The company added the US FDA approved Hydroxyprogesterone Caproate Injection, USP is the only preservative free generic alternative to Makena.

In conjunction, Hydroxyprogesterone Caproate Injection, USP can be ordered through wholesalers/distributors within the next several days,said the company.

With a history in generic specialty injectables, the company is engaged in the development, manufacturing and sales of generic and branded IV products.